Traditional allergy treatments are known to be inconvenient. For people who rely on immunotherapy, the process often involves routine visits to a clinic for allergy shots—a commitment that can last ...

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection against ...

Here are the top 5 AJMC.com articles and videos on allergy for 2025.

Peanut oral immunotherapy is generally safe, but rare, severe immediate allergic reactions may emerge months into treatment, ...

Before allergy medicine, there were a whole slew of bizarre ways to treat symptoms of what was known in the late 1800s as "hay fever." The term "allergy" didn't exist until 1906, says Theresa MacPhail ...

Children with peanut allergies may not need large doses of peanut oral immunotherapy (OIT) to build protection to peanut, ...

An existing asthma treatment shows promise for reducing food allergies in children and is one step closer to approval, which could come by the end of March. Early data from a federally funded clinical ...

Experts found that younger patients are more likely to achieve full remission. A peanut allergy treatment often used on children 4 years old and up in the U.S. appears to be safe for toddlers too, a ...

NEW YORK — Young children might be able to overcome their peanut allergies if treated at an early enough age, according to a study published Thursday. The researchers gave increasing amounts of peanut ...

Childhood peanut allergies are increasing in the U.S. This is a Kaiser Health News story. Whenever I see a report touting possible new peanut allergy treatments, I devour it. I can’t help it. It’s an ...

Australia, the ‘allergy capital of the world,’ has launched a world-first free nationwide treatment program for children with peanut allergies. The goal is to safely build tolerance to the troublesome ...

Xolair is a branded injectable medication used to treat allergic asthma, chronic hives, and rhinosinusitis. It’s recently been approved to manage food allergies, reducing the risk of serious reactions ...